Note: In these datasets, a person is defined as up to date if they have received at least one dose of an updated COVID-19 vaccine. The Centers for Disease Control and Prevention (CDC) recommends that certain groups, including adults ages 65 years and older, receive additional doses.

On 6/16/2023 CDPH replaced the booster measures with a new “Up to Date” measure based on CDC’s new recommendations, replacing the primary series, boosted, and bivalent booster metrics The definition of “primary series complete” has not changed and is based on previous recommendations that CDC has since simplified. A person cannot complete their primary series with a single dose of an updated vaccine. Whereas the booster measures were calculated using the eligible population as the denominator, the new up to date measure uses the total estimated population. Please note that the rates for some groups may change since the up to date measure is calculated differently than the previous booster and bivalent measures.

This data is from the same source as the Vaccine Progress Dashboard at https://covid19.ca.gov/vaccination-progress-data/ which summarizes vaccination data at the county level by county of residence. Where county of residence was not reported in a vaccination record, the county of provider that vaccinated the resident is included. This applies to less than 1% of vaccination records. The sum of county-level vaccinations does not equal statewide total vaccinations due to out-of-state residents vaccinated in California.

These data do not include doses administered by the following federal agencies who received vaccine allocated directly from CDC: Indian Health Service, Veterans Health Administration, Department of Defense, and the Federal Bureau of Prisons.

Totals for the Vaccine Progress Dashboard and this dataset may not match, as the Dashboard totals doses by Report Date and this dataset totals doses by Administration Date. Dose numbers may also change for a particular Administration Date as data is updated.

Previous updates:

• On March 3, 2023, with the release of HPI 3.0 in 2022, the previous equity scores have been updated to reflect more recent community survey information. This change represents an improvement to the way CDPH monitors health equity by using the latest and most accurate community data available. The HPI uses a collection of data sources and indicators to calculate a measure of community conditions ranging from the most to the least healthy based on economic, housing, and environmental measures.

• Starting on July 13, 2022, the denominator for calculating vaccine coverage has been changed from age 5+ to all ages to reflect new vaccine eligibility criteria. Previously the denominator was changed from age 16+ to age 12+ on May 18, 2021, then changed from age 12+ to age 5+ on November 10, 2021, to reflect previous changes in vaccine eligibility criteria. The previous datasets based on age 16+ and age 5+ denominators have been uploaded as archived tables.

• Starting on May 29, 2021 the methodology for calculating on-hand inventory in the shipped/delivered/on-hand dataset has changed. Please see the accompanying data dictionary for details. In addition, this dataset is now down to the ZIP code level.

This dataset reports the daily reported number of the 7-day moving average rates of Deaths involving COVID-19 by vaccination status and by age group. Learn how the Government of Ontario is helping to keep Ontarians safe during the 2019 Novel Coronavirus outbreak. Effective November 14, 2024 this page will no longer be updated. Information about COVID-19 and other respiratory viruses is available on Public Health Ontario’s interactive respiratory virus tool: https://www.publichealthontario.ca/en/Data-and-Analysis/Infectious-Disease/Respiratory-Virus-Tool Data includes: * Date on which the death occurred * Age group * 7-day moving average of the last seven days of the death rate per 100,000 for those not fully vaccinated * 7-day moving average of the last seven days of the death rate per 100,000 for those fully vaccinated * 7-day moving average of the last seven days of the death rate per 100,000 for those vaccinated with at least one booster ##Additional notes As of June 16, all COVID-19 datasets will be updated weekly on Thursdays by 2pm. As of January 12, 2024, data from the date of January 1, 2024 onwards reflect updated population estimates. This update specifically impacts data for the 'not fully vaccinated' category. On November 30, 2023 the count of COVID-19 deaths was updated to include missing historical deaths from January 15, 2020 to March 31, 2023. CCM is a dynamic disease reporting system which allows ongoing update to data previously entered. As a result, data extracted from CCM represents a snapshot at the time of extraction and may differ from previous or subsequent results. Public Health Units continually clean up COVID-19 data, correcting for missing or overcounted cases and deaths. These corrections can result in data spikes and current totals being different from previously reported cases and deaths. Observed trends over time should be interpreted with caution for the most recent period due to reporting and/or data entry lags. The data does not include vaccination data for people who did not provide consent for vaccination records to be entered into the provincial COVaxON system. This includes individual records as well as records from some Indigenous communities where those communities have not consented to including vaccination information in COVaxON. “Not fully vaccinated” category includes people with no vaccine and one dose of double-dose vaccine. “People with one dose of double-dose vaccine” category has a small and constantly changing number. The combination will stabilize the results. Spikes, negative numbers and other data anomalies: Due to ongoing data entry and data quality assurance activities in Case and Contact Management system (CCM) file, Public Health Units continually clean up COVID-19, correcting for missing or overcounted cases and deaths. These corrections can result in data spikes, negative numbers and current totals being different from previously reported case and death counts. Public Health Units report cause of death in the CCM based on information available to them at the time of reporting and in accordance with definitions provided by Public Health Ontario. The medical certificate of death is the official record and the cause of death could be different. Deaths are defined per the outcome field in CCM marked as “Fatal”. Deaths in COVID-19 cases identified as unrelated to COVID-19 are not included in the Deaths involving COVID-19 reported. Rates for the most recent days are subject to reporting lags All data reflects totals from 8 p.m. the previous day. This dataset is subject to change.

About this Dataset

The data contains the following information:

Country- this is the country for which the vaccination information is provided; Country ISO Code - ISO code for the country; Date - date for the data entry; for some of the dates we have only the daily vaccinations, for others, only the (cumulative) total; Total number of vaccinations - this is the absolute number of total immunizations in the country; Total number of people vaccinated - a person, depending on the immunization scheme, will receive one or more (typically 2) vaccines; at a certain moment, the number of vaccination might be larger than the number of people; Total number of people fully vaccinated - this is the number of people that received the entire set of immunization according to the immunization scheme (typically 2); at a certain moment in time, there might be a certain number of people that received one vaccine and another number (smaller) of people that received all vaccines in the scheme; Daily vaccinations (raw) - for a certain data entry, the number of vaccination for that date/country; Daily vaccinations - for a certain data entry, the number of vaccination for that date/country; Total vaccinations per hundred - ratio (in percent) between vaccination number and total population up to the date in the country; Total number of people vaccinated per hundred - ratio (in percent) between population immunized and total population up to the date in the country; Total number of people fully vaccinated per hundred - ratio (in percent) between population fully immunized and total population up to the date in the country; Number of vaccinations per day - number of daily vaccination for that day and country; Daily vaccinations per million - ratio (in ppm) between vaccination number and total population for the current date in the country; Vaccines used in the country - total number of vaccines used in the country (up to date); Source name - source of the information (national authority, international organization, local organization etc.); Source website - website of the source of information;

Tasks: Track the progress of COVID-19 vaccination What vaccines are used and in which countries? What country is vaccinated more people? What country is vaccinated a larger percent from its population?

This data is valuble in relation to the health, financial, and engineering sectors.

Category

Health & Medicine

Keywords

Health,Medicine,covid-19,dataset,progress

Row Count

5824

Price

$120.00

Regarding all Vaccination Data The date of Last Update is 4/21/2023. Additionally on 4/27/2023 several COVID-19 datasets were retired and no longer included in public COVID-19 data dissemination. See this link for more information https://imap.maryland.gov/pages/covid-data Summary The cumulative number of COVID-19 vaccinations percent age group population: 16-17; 18-49; 50-64; 65 Plus. Description COVID-19 - Vaccination Percent Age Group Population data layer is a collection of COVID-19 vaccinations that have been reported each day into ImmuNet. COVID-19 is a disease caused by a respiratory virus first identified in Wuhan, Hubei Province, China in December 2019. COVID-19 is a new virus that hasn't caused illness in humans before. Worldwide, COVID-19 has resulted in thousands of infections, causing illness and in some cases death. Cases have spread to countries throughout the world, with more cases reported daily. The Maryland Department of Health reports daily on COVID-19 cases by county. Terms of Use The Spatial Data, and the information therein, (collectively the Data) is provided as is without warranty of any kind, either expressed, implied, or statutory. The user assumes the entire risk as to quality and performance of the Data. No guarantee of accuracy is granted, nor is any responsibility for reliance thereon assumed. In no event shall the State of Maryland be liable for direct, indirect, incidental, consequential or special damages of any kind. The State of Maryland does not accept liability for any damages or misrepresentation caused by inaccuracies in the Data or as a result to changes to the Data, nor is there responsibility assumed to maintain the Data in any manner or form. The Data can be freely distributed as long as the metadata entry is not modified or deleted. Any data derived from the Data must acknowledge the State of Maryland in the metadata. This map is for planning purposes only. MEMA does not guarantee the accuracy of any forecast or predictive elements.

Age-standardised mortality rates for deaths involving coronavirus (COVID-19), non-COVID-19 deaths and all deaths by vaccination status, broken down by age group.

This dataset reports the number of individuals vaccinated against yellow fever per 100,000 people, providing insights into immunization coverage and population protection levels.

IntroductionIn December 2021, a large-scale epidemic broke out in Xi’an, China, due to SARS-CoV-2 infection. This study reports the effect of vaccination on COVID-19 and evaluates the impact of different vaccine doses on routine laboratory markers.MethodsThe laboratory data upon admission, of 231 cases with COVID-19 hospitalized from December 8, 2021 to January 20, 2022 in Xi’an, including blood routine, lymphocyte subtypes, coagulative function tests, virus specific antibodies and blood biochemical tests were collected and analyzed.ResultsOf the 231 patients, 21 were not vaccinated, 158 were vaccinated with two doses and 52 with three doses. Unvaccinated patients had a higher proportion of moderate and severe symptoms than vaccinated patients, while two-dose vaccinated patients had a higher proportion than three-dose vaccinated patients. SARS-CoV-2 specific IgG levels were significantly elevated in vaccinated patients compared with unvaccinated patients. Particularly, unvaccinated patients had lower counts and percentages of lymphocytes, eosinophils and CD8+ T-lymphocytes, and elevated coagulation-related markers. In addition, vaccination had no effect on liver and kidney function.ConclusionsVaccination against SARS-CoV-2, inducing high IgG level and increased CD8+ T cells and eosinophils, and regulating coagulation function, can significantly attenuate symptoms of COVID-19, suggesting that the vaccine remains protective against SARS-CoV-2.

Abstract

A strong evidence base is needed to understand the socioeconomic implications of the coronavirus pandemic for the Solomon Islands. High Frequency Phone Surveys (HFPS) are set up to understand these implications over the years. This data is the fifth of the five planned rounds of mobile surveys. Four rounds of the HFPS are already completed in June 2020 (Round 1), Dec 2020-Jan 2021 (Round 2), July-Aug 2021 (Round 3) and Jan 2022-Feb 2022 (Round 4), Round 5 interviewed 2,507 households across the country between July 30, 2022, and September 8, 2022, on topics including vaccines of COVID-19, employment, income, food security, health, and coping strategies, and public trust and security.

Geographic coverage

Urban and rural areas of Solomon Islands.

Analysis unit

Household and Individual.

Universe

All respondents must be aged 18 and over and have a phone.

Kind of data

Sample survey data [ssd]

Sampling procedure

As the objective of the survey was to measure changes as the pandemic progresses, Round Five data collection sought to re-contact all 2,671 households contacted in Round Four. The protocols for re-contact were a maximum of 3 attempts per caller shift, spaced between 1.5 and 2.5 hours apart depending on whether the phone was busy or there was no answer, and 15 attempts in total. A new survey company (Sistemas) was hired for the fifth round, and the old survey company (Tebbutt) did not provide the phone numbers of the old households contacted in previous rounds. Hence, no returning households can be identified in round 5. In Round Five, Honiara was over-represented in the World Bank HFPS (constituting 47.7 percent of the survey sample). All other provinces were deemed under-represented, with the largest differences being for Malaita and Western, which represented 9.5 percent (Census: 21.4 percent), and 12.5 percent of the survey sample (Census: 21.4 percent), respectively. Urban areas constituted 58.3 percent of the survey sample, compared to a quarter (25.6 percent) of the census. The target geographic distribution for the survey was based on the population distribution across provinces from the preliminary 2019 census results. According to the population census, Honiara constituted almost one quarter (18.0 percent) of the total population. Compensating factors for these differences were developed and included in the re-weighting calculations.

Due to the limited sample sizes outside of Honiara, most results are disaggregated into only three geographic regions: Honiara, other urban areas, and rural areas. For more information on sampling, please refer to the presentation slides provided in the External Resources.

Mode of data collection

Computer Assisted Telephone Interview [cati]

Research instrument

The questionnaire - that can be found in the External Resources of this documentation - was developed both in English and in Solomons Pijin. The survey instrument for the fifth round consisted of the following modules: -Basic information, -Information about COVID-19, -Vaccines of COVID-19, -Health, -Education, -Access food & food security, -Employment and Income, -Coping strategies, -Public trust and security, -and Assets and wellbeing.

Cleaning operations

At the end of data collection, the dataset was cleaned by the World Bank team. This included formatting, and correcting results based on monitoring issues, enumerator feedback and survey changes. Data was edited using Stata.
The data is presented in three data sets: household data set, individual data set, and child data set. The total number of observations in the household data set is 2,507 in the individual data set and is 1,260 in the child data set. The child data set contains the education information for children of all households who answered this section, the individual data set contains the employment and vaccine information for all individuals, and the household data set contains information about health, access food & food security, coping strategies, public trust and security, and assets and well-being.

This dataset reports the number of individuals vaccinated against yellow fever per 100,000 surviving infants, providing insights into immunization coverage and population protection levels.

SummaryThe cumulative number of COVID-19 vaccinations percent age group population: 16-17; 18-49; 50-64; 65 Plus.DescriptionMD COVID-19 - Vaccination Percent Age Group Population data layer is a collection of COVID-19 vaccinations that have been reported each day into ImmuNet.COVID-19 is a disease caused by a respiratory virus first identified in Wuhan, Hubei Province, China in December 2019. COVID-19 is a new virus that hasn't caused illness in humans before. Worldwide, COVID-19 has resulted in thousands of infections, causing illness and in some cases death. Cases have spread to countries throughout the world, with more cases reported daily. The Maryland Department of Health reports daily on COVID-19 cases by county.

Breakthrough SARS-CoV-2 infections have been reported in fully vaccinated individuals, in spite of the high efficacy of the currently available vaccines, proven in trials and real-world studies. Several variants of concern (VOC) have been proffered to be associated with breakthrough infections following immunization. In this study, we investigated 378 breakthrough infections recorded between January and July 2021 and compared the distribution of SARS-CoV-2 genotypes identified in 225 fully vaccinated individuals to the frequency of circulating community lineages in the region of South Limburg (The Netherlands) in a week-by-week comparison. Although the proportion of breakthrough infections was relatively low and stable when the Alpha variant was predominant, the rapid emergence of the Delta variant lead to a strong increase in breakthrough infections, with a higher relative proportion of individuals vaccinated with Vaxzevria or Jcovden being infected compared to those immunized with mRNA-based vaccines. A significant difference in median age was observed when comparing fully vaccinated individuals with severe symptoms (83 years) to asymptomatic cases (46.5 years) or individuals with mild-to-moderate symptoms (42 years). There was no association between SARS-CoV-2 genotype or vaccine type and disease symptoms. Furthermore, the majority of adaptive mutations were concentrated in the N-terminal domain of the Spike protein, highlighting its role in immune evasion. Interestingly, symptomatic individuals harbored significantly higher SARS-CoV-2 loads than asymptomatic vaccinated individuals and breakthrough infections caused by the Delta variant were associated with increased viral loads compared to those caused by the Alpha variant. In addition, we investigated the role of the Omicron variant in causing breakthrough infections by analyzing 135 samples that were randomly selected for genomic surveillance during the transition period from Delta to Omicron. We found that the proportion of Omicron vs. Delta infections was significantly higher in individuals who received a booster vaccine compared to both unvaccinated and fully vaccinated individuals. Altogether, these results indicate that the emergence of the Delta variant and in particular Omicron has lowered the efficiency of particular vaccine types to prevent SARS-CoV-2 infections and that, although rare, the elderly are particularly at risk of becoming severely infected as the consequence of a breakthrough infection.

Switzerland Immunization: DPT: % of Children Aged 12-23 Months data was reported at 97.000 % in 2016. This stayed constant from the previous number of 97.000 % for 2015. Switzerland Immunization: DPT: % of Children Aged 12-23 Months data is updated yearly, averaging 93.000 % from Dec 1986 (Median) to 2016, with 31 observations. The data reached an all-time high of 97.000 % in 2016 and a record low of 88.000 % in 1998. Switzerland Immunization: DPT: % of Children Aged 12-23 Months data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Switzerland – Table CH.World Bank: Health Statistics. Child immunization, DPT, measures the percentage of children ages 12-23 months who received DPT vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against diphtheria, pertussis (or whooping cough), and tetanus (DPT) after receiving three doses of vaccine.; ; WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).; Weighted average;

France FR: Immunization: DPT: % of Children Aged 12-23 Months data was reported at 96.000 % in 2017. This stayed constant from the previous number of 96.000 % for 2016. France FR: Immunization: DPT: % of Children Aged 12-23 Months data is updated yearly, averaging 97.000 % from Dec 1990 (Median) to 2017, with 28 observations. The data reached an all-time high of 99.000 % in 2013 and a record low of 94.000 % in 1993. France FR: Immunization: DPT: % of Children Aged 12-23 Months data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s France – Table FR.World Bank: Health Statistics. Child immunization, DPT, measures the percentage of children ages 12-23 months who received DPT vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against diphtheria, pertussis (or whooping cough), and tetanus (DPT) after receiving three doses of vaccine.; ; WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).; Weighted average;

El Salvador SV: Immunization: DPT: % of Children Aged 12-23 Months data was reported at 93.000 % in 2016. This records an increase from the previous number of 91.000 % for 2015. El Salvador SV: Immunization: DPT: % of Children Aged 12-23 Months data is updated yearly, averaging 90.000 % from Dec 1980 (Median) to 2016, with 37 observations. The data reached an all-time high of 99.000 % in 2007 and a record low of 21.000 % in 1983. El Salvador SV: Immunization: DPT: % of Children Aged 12-23 Months data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s El Salvador – Table SV.World Bank: Health Statistics. Child immunization, DPT, measures the percentage of children ages 12-23 months who received DPT vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against diphtheria, pertussis (or whooping cough), and tetanus (DPT) after receiving three doses of vaccine.; ; WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).; Weighted average;

Latvia LV: Immunization: DPT: % of Children Aged 12-23 Months data was reported at 98.000 % in 2017. This stayed constant from the previous number of 98.000 % for 2016. Latvia LV: Immunization: DPT: % of Children Aged 12-23 Months data is updated yearly, averaging 94.500 % from Dec 1992 (Median) to 2017, with 26 observations. The data reached an all-time high of 99.000 % in 2005 and a record low of 80.000 % in 1993. Latvia LV: Immunization: DPT: % of Children Aged 12-23 Months data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Latvia – Table LV.World Bank.WDI: Health Statistics. Child immunization, DPT, measures the percentage of children ages 12-23 months who received DPT vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against diphtheria, pertussis (or whooping cough), and tetanus (DPT) after receiving three doses of vaccine.; ; WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).; Weighted average;

Libya LY: Immunization: DPT: % of Children Aged 12-23 Months data was reported at 97.000 % in 2016. This stayed constant from the previous number of 97.000 % for 2015. Libya LY: Immunization: DPT: % of Children Aged 12-23 Months data is updated yearly, averaging 95.000 % from Dec 1980 (Median) to 2016, with 37 observations. The data reached an all-time high of 98.000 % in 2012 and a record low of 60.000 % in 1980. Libya LY: Immunization: DPT: % of Children Aged 12-23 Months data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Libya – Table LY.World Bank: Health Statistics. Child immunization, DPT, measures the percentage of children ages 12-23 months who received DPT vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against diphtheria, pertussis (or whooping cough), and tetanus (DPT) after receiving three doses of vaccine.; ; WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).; Weighted average;

Haiti HT: Immunization: DPT: % of Children Aged 12-23 Months data was reported at 58.000 % in 2016. This records a decrease from the previous number of 60.000 % for 2015. Haiti HT: Immunization: DPT: % of Children Aged 12-23 Months data is updated yearly, averaging 42.000 % from Dec 1980 (Median) to 2016, with 37 observations. The data reached an all-time high of 68.000 % in 2013 and a record low of 3.000 % in 1980. Haiti HT: Immunization: DPT: % of Children Aged 12-23 Months data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Haiti – Table HT.World Bank: Health Statistics. Child immunization, DPT, measures the percentage of children ages 12-23 months who received DPT vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against diphtheria, pertussis (or whooping cough), and tetanus (DPT) after receiving three doses of vaccine.; ; WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).; Weighted average;

Honduras HN: Immunization: DPT: % of Children Aged 12-23 Months data was reported at 97.000 % in 2016. This stayed constant from the previous number of 97.000 % for 2015. Honduras HN: Immunization: DPT: % of Children Aged 12-23 Months data is updated yearly, averaging 94.000 % from Dec 1980 (Median) to 2016, with 37 observations. The data reached an all-time high of 98.000 % in 2005 and a record low of 28.000 % in 1980. Honduras HN: Immunization: DPT: % of Children Aged 12-23 Months data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Honduras – Table HN.World Bank: Health Statistics. Child immunization, DPT, measures the percentage of children ages 12-23 months who received DPT vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against diphtheria, pertussis (or whooping cough), and tetanus (DPT) after receiving three doses of vaccine.; ; WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).; Weighted average;

Malawi MW: Immunization: DPT: % of Children Aged 12-23 Months data was reported at 84.000 % in 2016. This records a decrease from the previous number of 88.000 % for 2015. Malawi MW: Immunization: DPT: % of Children Aged 12-23 Months data is updated yearly, averaging 87.000 % from Dec 1980 (Median) to 2016, with 37 observations. The data reached an all-time high of 99.000 % in 2006 and a record low of 55.000 % in 1985. Malawi MW: Immunization: DPT: % of Children Aged 12-23 Months data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Malawi – Table MW.World Bank: Health Statistics. Child immunization, DPT, measures the percentage of children ages 12-23 months who received DPT vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against diphtheria, pertussis (or whooping cough), and tetanus (DPT) after receiving three doses of vaccine.; ; WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).; Weighted average;

Nigeria NG: Immunization: DPT: % of Children Aged 12-23 Months data was reported at 49.000 % in 2016. This stayed constant from the previous number of 49.000 % for 2015. Nigeria NG: Immunization: DPT: % of Children Aged 12-23 Months data is updated yearly, averaging 36.000 % from Dec 1984 (Median) to 2016, with 33 observations. The data reached an all-time high of 63.000 % in 2009 and a record low of 9.000 % in 1984. Nigeria NG: Immunization: DPT: % of Children Aged 12-23 Months data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Nigeria – Table NG.World Bank: Health Statistics. Child immunization, DPT, measures the percentage of children ages 12-23 months who received DPT vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against diphtheria, pertussis (or whooping cough), and tetanus (DPT) after receiving three doses of vaccine.; ; WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).; Weighted average;